Ligand ID: BHA Drugbank ID: DB00233(Aminosalicylic Acid) Indication:For the treatment of tuberculosis |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.57A | 17.58 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 115VAL A 13LEU A 30VAL A 157 | 1.76A | 17.58 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.54A | 17.58 | NoneDMS A 401 (-3.4A)NoneNone | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.34A | 17.58 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 20 | 1.77A | 17.58 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.42A | 17.58 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 6 | LEU B 984ARG C 983VAL B 987ARG A 983VAL A 987 | 1.66A | 21.69 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.32A | 20.21 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m03 | MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.31A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.33A | 20.26 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU B 262VAL B 261LEU B 205VAL B 247 | 1.30A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.47A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU B 89VAL B 68LEU B 75VAL B 18 | 1.44A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.45A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.36A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU C 75ARG C 76VAL C 91VAL C 36 | 1.51A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU D 262VAL D 261LEU D 205VAL D 247 | 1.38A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU D 75ARG D 76VAL D 91VAL D 36 | 1.60A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU C 262VAL C 261LEU C 205VAL C 247 | 1.47A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.60A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.31A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.57A | 20.13 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.44A | 20.13 | None | ||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 10 | GLY A 179VAL A 182LEU A 245TYR A 286ALA A 185 | 1.66A | 17.32 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 241ARG A 132LEU A 131VAL A 182 | 1.60A | 10.91 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | ARG A 750VAL A 475LEU A 749VAL A 472 | 1.47A | 10.91 | None | ||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | GLY A 857VAL A 736LEU A1004TYR A1007LEU A 962 | 1.43A | 14.52 | None | ||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.45A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.23A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.62A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.21A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.53A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 10 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.76A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 141VAL A 120LEU A 118VAL A 127 | 1.34A | 8.64 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w02 | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.17A | 20.88 | None | ||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.44A | 19.24 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.47A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.35A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | VAL B 16LEU B 153ARG B 141VAL B 144 | 1.77A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.15A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | VAL A 95LEU A 127TYR A 113LEU A 109SER A 128 | 1.78A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 9 | VAL A 95LEU A 127TYR A 113LEU A 109SER A 128 | 1.75A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.38A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.62A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | GLY B 130LEU B 126TYR B 113LEU B 109ALA B 38 | 1.64A | MES B 201 ( 3.4A)NoneNoneNoneMES B 201 ( 3.4A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 122VAL A 36LEU A 127VAL A 95 | 1.74A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.13A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.63A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.46A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 122VAL A 151ARG A 148VAL A 147 | 1.74A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 140ARG A 141VAL A 144VAL A 16 | 1.20A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | ARG C6864VAL A7094LEU C6892VAL A7092 | 1.75A | 19.66 | FMT C7106 ( 2.7A)NoneNoneNone | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | VAL A7094LEU C6892ARG C7081VAL C7086 | 1.78A | 19.66 | None | ||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 5 / 10 | GLY A 100LEU A 106TYR A 31LEU A 9SER A 105 | 1.80A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.15A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.37A | NoneNoneNoneNoneMES A 201 ( 4.7A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.63A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 130LEU A 126TYR A 113LEU A 109ALA A 38 | 1.61A | MES A 201 (-3.2A)NoneNoneNoneMES A 201 (-3.6A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.56A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wen | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.18A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 10 | VAL A 95LEU A 127TYR A 113LEU A 109SER A 128 | 1.79A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wen | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 140ARG A 141VAL A 144VAL A 16 | 1.25A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 9 | VAL A 299LEU A 331TYR A 317LEU A 313SER A 332 | 1.77A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 10 | VAL A 299LEU A 331TYR A 317LEU A 313SER A 332 | 1.79A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wey | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 357VAL A 355LEU A 326VAL A 351 | 1.17A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wey | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 216VAL A 220LEU A 357VAL A 348 | 1.61A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 10 | GLY A 283VAL A 299LEU A 297TYR A 272ALA A 243 | 1.35A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU B 3VAL B 25LEU B 43VAL B 23 | 1.60A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU A 3VAL A 25LEU A 43VAL A 23 | 1.61A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.35A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY B 130LEU B 126TYR B 113LEU B 109ALA B 38 | 1.59A | APR B 201 (-3.3A)NoneNoneNoneAPR B 201 (-3.3A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.60A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.13A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.41A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 153VAL D 151LEU D 122VAL D 147 | 1.14A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.14A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | VAL D 95LEU D 127TYR D 113LEU D 109SER D 128 | 1.74A | NoneNoneNoneNoneAPR D 201 (-4.3A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY D 130LEU D 126TYR D 113LEU D 109ALA D 38 | 1.58A | APR D 201 (-3.2A)NoneNoneNoneAPR D 201 (-3.2A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.61A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.36A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 12VAL D 16LEU D 153VAL D 144 | 1.61A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY C 130LEU C 126TYR C 113LEU C 109ALA C 38 | 1.60A | APR C 201 (-3.0A)APR C 201 (-4.9A)NoneNoneAPR C 201 (-3.4A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY A 130LEU A 126TYR A 113LEU A 109ALA A 38 | 1.61A | APR A 201 (-3.5A)NoneNoneNoneAPR A 201 (-3.5A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY C 79VAL C 95LEU C 93TYR C 68ALA C 39 | 1.41A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.74A | NoneNoneNoneNoneAPR B 201 (-4.5A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.78A | NoneNoneNoneNoneAPR B 201 (-4.5A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | GLY D 79VAL D 95LEU D 93TYR D 68ALA D 39 | 1.34A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU C 153VAL C 151LEU C 122VAL C 147 | 1.18A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | VAL D 95LEU D 127TYR D 113LEU D 109SER D 128 | 1.78A | NoneNoneNoneNoneAPR D 201 (-4.3A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.38A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.31A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 10 | GLY A 160VAL A 159LEU A 113TYR A 112ALA A 86 | 1.70A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.59A | 18.18 | DMS A 408 (-3.3A)NoneNoneNone | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 20 | 1.77A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.45A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 115VAL A 13LEU A 30VAL A 157 | 1.78A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.35A | 18.18 | None | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.54A | 18.18 | NoneDMS A 401 (-3.4A)NoneNone | ||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.46A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.38A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.51A | NoneDMS A 501 (-3.1A)NoneNone | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.63A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.33A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.59A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 75ARG A 76VAL A 91VAL A 36 | 1.58A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 27VAL A 20LEU A 89VAL A 18 | 1.62A | PK8 A 401 ( 3.6A)NoneNoneNone | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.41A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153VAL E 151LEU E 122VAL E 147 | 1.17A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.23A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.76A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 12VAL C 16LEU C 153VAL C 144 | 1.62A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 140ARG E 141VAL E 144VAL E 16 | 1.31A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153VAL C 151LEU C 122VAL C 147 | 1.18A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY E 79VAL E 95LEU E 93TYR E 68ALA E 39 | 1.42A | EPE E 203 (-3.3A)NoneNoneNoneNone | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.79A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 12VAL D 16LEU D 153VAL D 144 | 1.63A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY E 130LEU E 126TYR E 113LEU E 109ALA E 38 | 1.74A | EPE E 202 ( 4.5A)NoneNoneNoneEPE E 202 (-3.3A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY C 79VAL C 95LEU C 93TYR C 68ALA C 39 | 1.40A | EPE C 202 (-3.4A)NoneNoneNoneNone | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 130LEU A 126TYR A 113LEU A 109ALA A 38 | 1.74A | EDO A 202 ( 4.4A)NoneNoneNoneEDO A 202 (-3.3A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.42A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY C 130LEU C 126TYR C 113LEU C 109ALA C 38 | 1.75A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.61A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.41A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY D 79VAL D 95LEU D 93TYR D 68ALA D 39 | 1.49A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.63A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153VAL D 151LEU D 122VAL D 147 | 1.18A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.18A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.23A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153VAL D 151LEU D 122VAL D 147 | 1.20A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY E 79VAL E 95LEU E 93TYR E 68ALA E 39 | 1.44A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | VAL A 95LEU A 127TYR A 113LEU A 109SER A 128 | 1.79A | NoneNoneNoneNoneAPR A 201 (-4.4A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY D 130LEU D 126TYR D 113LEU D 109ALA D 38 | 1.66A | APR D 201 (-3.2A)APR D 201 (-4.5A)NoneNoneAPR D 201 (-3.3A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 130LEU A 126TYR A 113LEU A 109ALA A 38 | 1.63A | APR A 201 ( 3.2A)APR A 201 (-4.8A)NoneNoneAPR A 201 (-3.4A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 140ARG E 141VAL E 144VAL E 16 | 1.24A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 12VAL D 16LEU D 153VAL D 144 | 1.59A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY E 130LEU E 126TYR E 113LEU E 109ALA E 38 | 1.64A | APR E 201 (-3.2A)APR E 201 (-4.7A)NoneNoneAPR E 201 (-3.3A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 12VAL E 16LEU E 153VAL E 144 | 1.63A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.20A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY B 130LEU B 126TYR B 113LEU B 109ALA B 38 | 1.65A | APR B 201 (-3.2A)APR B 201 (-4.7A)NoneNoneAPR B 201 (-3.4A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 12VAL C 16LEU C 153VAL C 144 | 1.61A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 12VAL A 16LEU A 153VAL A 144 | 1.60A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY C 130LEU C 126TYR C 113LEU C 109ALA C 38 | 1.66A | APR C 201 (-3.2A)APR C 201 (-4.8A)NoneNoneAPR C 201 (-3.4A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.44A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | VAL C 95LEU C 127TYR C 113LEU C 109SER C 128 | 1.80A | NoneNoneNoneNoneAPR C 201 (-4.4A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.59A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY D 79VAL D 95LEU D 93TYR D 68ALA D 39 | 1.50A | EDO D 203 (-3.1A)NoneNoneEDO D 202 (-4.3A)None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY C 79VAL C 95LEU C 93TYR C 68ALA C 39 | 1.42A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | VAL B 95LEU B 127TYR B 113LEU B 109SER B 128 | 1.79A | NoneNoneNoneNoneAPR B 201 (-4.3A) | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.45A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | VAL D 95LEU D 127TYR D 113LEU D 109SER D 128 | 1.80A | NoneNoneNoneNoneAPR D 201 (-4.3A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153VAL E 151LEU E 122VAL E 147 | 1.15A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153VAL C 151LEU C 122VAL C 147 | 1.17A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153VAL B 151LEU B 122VAL B 147 | 1.19A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY B 79VAL B 95LEU B 93TYR B 68ALA B 39 | 1.43A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 79VAL A 95LEU A 93TYR A 68ALA A 39 | 1.40A | EDO A 204 (-3.6A)NoneNoneNoneNone | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY B 130LEU B 126TYR B 113LEU B 109ALA B 38 | 1.76A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY A 130LEU A 126TYR A 113LEU A 109ALA A 38 | 1.62A | MES A 201 (-3.1A)NoneNoneNoneMES A 201 (-3.5A) | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153VAL C 151LEU C 122VAL C 147 | 1.17A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 12VAL B 16LEU B 153VAL B 144 | 1.63A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | GLY C 79VAL C 95LEU C 93TYR C 68ALA C 39 | 1.36A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153VAL A 151LEU A 122VAL A 147 | 1.19A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 12VAL C 16LEU C 153VAL C 144 | 1.62A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | ARG A 40VAL A 42LEU A 87VAL A 20 | 1.61A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.32A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 89VAL A 68LEU A 75VAL A 18 | 1.47A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 9 | LEU A 514TYR A 515SER A 518ARG B 80ALA B 86 | 1.40A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7btf | NSP8 (SARS-CoV-2) | 4 / 6 | LEU D 184VAL D 159LEU D 169VAL D 167 | 1.55A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 10 | GLY A 179VAL A 182LEU A 245TYR A 286ALA A 185 | 1.61A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 10 | VAL A 182LEU A 241TYR A 237TYR A 286ALA A 185 | 1.53A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | LEU A 262VAL A 261LEU A 205VAL A 247 | 1.30A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 10 | GLY A 179VAL A 182LEU A 245TYR A 286ALA A 185 | 1.70A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 241ARG A 132LEU A 131VAL A 182 | 1.49A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 10 | GLY A 179VAL A 182LEU A 241TYR A 286ALA A 185 | 1.74A | None | |||
![]() | 1PBC_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 10 | VAL A 182LEU A 241TYR A 237TYR A 286ALA A 185 | 1.54A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | ARG A 750VAL A 475LEU A 749VAL A 472 | 1.57A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 9 | LEU A 514TYR A 515SER A 518ARG B 80ALA B 86 | 1.58A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 638ARG A 631VAL A 693VAL A 476 | 1.60A | None | |||
![]() | 1PBF_A_BHAA396_0 (P-HYDROXYBENZOATEHYDROXYLASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 9 | LEU A 514TYR A 515SER A 518ARG B 80ALA B 86 | 1.66A | None | |||
![]() | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | ARG A 750VAL A 475LEU A 749VAL A 472 | 1.52A | None |